GlassScriptPhysician profile
Annalisa Yu Co
NPI 1528060548
$3,826.72
in general payments reported to CMS, 2019-2025
24 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $221 · 2021: $1,470 · 2022: $506 · 2023: $721 · 2024: $228 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,113 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.61 |
| Education | $280.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sequoia Surgical, INC. | $1,200.00 | 2021 | |
| Smith+Nephew, INC. | $617.77 | 2019-2025 | Collagenase Santyl, Regranex, Integra |
| Mimedx Group, INC. | $392.03 | 2024-2025 | |
| Djo, LLC | $280.00 | 2023 | Dr Comfort |
| Organogenesis INC. | $229.82 | 2020-2025 | Affinity, Puraply |
| Zimmer Biomet Holdings, INC. | $179.15 | 2019-2021 | |
| Paragon 28, INC. | $91.56 | 2019-2022 | |
| Bioventus LLC | $86.86 | 2019-2022 | |
| Horizon Therapeutics Plc | $85.23 | 2023 | Krystexxa |
| Treace Medical Concepts, INC. | $80.20 | 2023-2025 | |
| Integra Lifesciences Corporation | $74.27 | 2021 | |
| Next Science LLC | $65.68 | 2022-2023 | Surgx, Xperience, Blastx |
| Orthofix Medical, INC. | $64.57 | 2021-2022 | |
| Averitas Pharma INC. | $56.29 | 2023-2024 | Qutenza |
| Nevro Corp. | $54.55 | 2022-2024 | Senza |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $39.41 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $38.86 | 2019 | |
| Acell, INC. | $34.23 | 2020 | |
| Zimvie INC. | $32.53 | 2022 | |
| Curonix LLC | $28.99 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Alfasigma USA, INC. | $28.28 | 2021 | |
| Osiris Therapeutics INC. | $27.77 | 2019 | |
| Biotissue Holdings INC. | $24.72 | 2021 | |
| Medela LLC | $13.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annalisa Co listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.